Public health experts credit PrEP for declines in new HIV infections, about 32,000 in 2022. The treatment, available as daily pills or periodic injections, offers an additional layer of protection ...

British pharma giant GSK on Wednesday announced promising results for a long-acting injectable HIV therapy, offering a hopeful alternative for people who take daily pills to halt the virus’s ...

Human trials of a once-a-week oral pill for HIV could start, after successful tests in pigs, claim US scientists. The slow-release tablet could free patients from having to take daily medication ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a pair of HIV prevention pills in a case that raised questions about the ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a pair of HIV prevention pills in a case that raised questions about the ...